Balance and eye movement training to improve gait in people with progressive supranuclear palsy: Quasi-randomized clinical trial

Physical Therapy

Volumn 88, Issue 12, 2008, Pages 1460-1473

  Zampieri, Cris ^a   Di Fabio, Richard P ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Department of Physical Medicine and Rehabilitation ^*

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EYE MOVEMENT; FALLING; FEMALE; GAIT; HUMAN; KINEMATICS; MALE; MINI MENTAL STATE EXAMINATION; PATIENT MOBILITY; PROGRESSIVE SUPRANUCLEAR PALSY; PROPRIOCEPTION; QUASI EXPERIMENTAL STUDY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RISK; SCORING SYSTEM; TASK PERFORMANCE; TRAINING; TREATMENT OUTCOME; UNIFIED PARKINSON DISEASE RATING SCALE; WALKING SPEED;

AGED; EXERCISE THERAPY; EYE MOVEMENTS; FEMALE; GAIT; GAIT DISORDERS, NEUROLOGIC; HUMANS; MALE; POSTURAL BALANCE; SUPRANUCLEAR PALSY, PROGRESSIVE; TREATMENT OUTCOME;

EID: 57149083876     PISSN: 00319023     EISSN: None     Source Type: Journal    
DOI: 10.2522/ptj.20070302     Document Type: Article

References (62)

1. Nath U, Ben-Shlomo Y, Tomson RG, et al. Clinical features and natural history of progressive supranuclear palsy: a clinical cohort study. Neurology. 2003;60:910-916.
2. Birdi S, Rajput AH, Fenton M, et al. Progressive supranuclear palsy diagnosis and confounding features: report on 16 autopsied cases. Mov Disord. 2002;17:1255-1264.
3. Litvan I. Diagnosis and management of progressive supranuclear palsy. Semin Neurol. 2001;21:41-48.
4. Goetz CG, Leurgans S, Lang AE, Litvan I. Progression of gait, speech and swallowing deficits in progressive supranuclear palsy. Neurology. 2003;60:917-922.
5. Duvoisin RC, Golbe LI, Lepore FE. Progressive supranuclear palsy. Can J Neurol Sci. 1987;14:547-554.
6. Golbe GI, Davis PH, Shoenberg BS, Duvoisin RC. Prevalence and natural history of progressive supranuclear palsy. Neurology. 1988;38:1031-1034.
7. Di Fabio RP, Zampieri C, Tuite P. Gazeshift strategies during functional activity in progressive supranuclear palsy. Exp Brain Res. 2006;178:351-362.
8. Di Fabio RP, Zampieri C, Tuite P, Konczak J. Independent gaze theory supported by progressive supranuclear palsy. In: 34th Annual Meeting of the Society for Neuroscience. San Diego, CA: Society for Neuroscience; 2004.
9. Di Fabio RP, Zampieri C, Tuite P, Konczak J. Association between vestibuloocular reflex suppression during smooth movements of the head and attention deficit in progressive supranuclear palsy. Mov Disord. 2006;21:910-915.
10. Muller J, Seppi K, Stefanova N, et al. Freezing of gait in postmortem-confirmed atypical parkinsonism. Mov Disord. 2002;17: 1041-1045.
11. Burn DJ, Lees AJ. Progressive supranuclear palsy: where are we now? Lancet. 2002;1:359-369.
12. Izzo KL, DiLorenzo P, Roth A. Rehabilitation in progressive supranuclear palsy: case report. Arch Phys Med Rehabil. 1996;67:473-476.
13. Sosner J, Wall GC, Sznajder J. Progressive supranuclear palsy: clinical presentation and rehabilitation of two patients. Arch Phys Med Rehabil. 1993;74:537-539.
14. Steffen TM, Bradley FB, Mollinger-Riemann LA, Petersen CM. Long-term locomotor training for gait and balance in a patient with mixed progressive supranuclear palsy and corticobasal degeneration. J Neurol Phys Ther. 2007;31:1078-1087.
15. Suteerawattananon MB, Neil BM, Elizabeth P. Supported treadmill training for gait balance in a patient with progressive supranuclear palsy. Phys Ther. 2002;82:485-495.
16. Patla AE, Vickers JN. Where and when do we look as we approach and step over an obstacle in the travel path? Neuroreport. 1997;8:3661-3665.
17. Hollands MA, Patla AE, Vickers JN. "Look where you're going!" Gaze behaviour associated with maintaining and changing the direction of locomotion. Exp Brain Res. 2002;143:221-230.
18. Di Fabio RP, Greany J, Zampieri C. Saccade-stepping interactions revise the motor plan for obstacle avoidance. J Mot Behav. 2003;35:383-397.
19. Di Fabio R, Zampieri C, Henke J, et al. Influence of elderly executive cognitive function on visual attention in the lower visual field. Gerontology. 2005;51:94-107.
20. Di Fabio R, Zampieri C, Tuite P. Gaze control and foot kinematics during stair climbing: characteristics leading to fall risk in progressive supranuclear palsy. Phys Ther. 2008;88:240-250.
21. Rubenstein LZ. Falls in older people: epidemiology, risk factors, and strategies for prevention. Age Ageing. 2006;35(suppl 2):ii37-ii41.
22. Sheridan P, Hausdorff J. The role of higher-level cognitive function in gait: executive dysfunction contributes to fall risk in Alzheimer's disease. Dement Geriatr Cogn Disord. 2007;24:125-137.
23. Hausdorff J, Doniger G, Springer S, et al. A common cognitive profile in elderly fallers and in patients with Parkinson's disease: the prominence of impaired executive function and attention. Exp Aging Res. 2006;32:411-429.
24. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12: 189-198.
25. Cubo E, Stebbins GT, Golbe LI, et al. Application of the Unified Parkinson's Disease Rating Scale in progressive supranuclear palsy: factor analysis of the motor scale. Mov Disord. 2000;15:276-279.
26. Golbe LI. A clinical rating scale for progressive supranuclear palsy. Brain. 2007; 130:1552-1565.
27. Litvan I, Bhatia KP, Burn DJ, et al. SIC task force appraisal of clinical diagnostic criteria for parkinsonian disorders. Mov Disord. 2003;18:467-486.
28. Comella C, Stebbins G, Brown-Toms N, Goetz C. Physical therapy and Parkinson's disease: a controlled clinical trial. Neurology. 1994;44:376-378.
29. Protas EJ, Mitchell K, Williams A, et al. Gait and step training to reduce falls in Parkinson's disease. NeuroRehabilitation. 2005;3:183-190.
30. Findorff M, Stock HH, Gross C, Wyman J. Does the transtheoretical model (TTM) explain exercise behavior in a community-based sample of older women? J Aging Health. 2007;19:985-1003.
31. Jöbges M, Heuschkel G, Pretzel C, et al. Repetitive training of compensatory steps: a therapeutic approach for postural instability in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2004;75:1682-1687.
32. Bailey M, Riddoch M, Crome P. Treatment of visual neglect in elderly patients with stroke: a single-subject series using either a scanning and cueing strategy or a left-limb activation strategy. Phys Ther. 2002;82:782-797.
33. Luauté J, Halligane P, Rodea G, et al. Visuospatial neglect: a systematic review of current interventions and their effectiveness. Neurosci Biobehav Rev. 2006;30:961-982.
34. Di Fabio RP, Zampieri C, Tuite P, Konczak J. Vertical gaze enhanced with biofeedback for patients with progressive supranuclear palsy: evidence for movement related plasticity in a chronic progressive neurological disorder [abstract]. Mov Disord. 2004;19:1124.
35. Sharma P, Tandon R, Kumar S, Anand S. Reduction of congenital nystagmus amplitude with auditory biofeedback. J AAPOS. 2000;4:287-290.
36. Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49:M85-M94.
37. Morris S, Morris ME, Iansek R. Reliability of measurements obtained with the Timed "Up & Go" Test in people with Parkinson disease. Phys Ther. 2001;81:810-818.
38. Jette AM, Jette DU, Ng J, et al. Are performance-based measures sufficiently reliable for use in multicenter trials? Musculoskeletal Impairment (MSI) Study Group. J Gerontol A Biol Sci Med Sci. 1999;54:M3-M6.
39. Lim LI, van Wegen EE, de Goede CJ, et al. Measuring gait and gait-related activities in Parkinson's patients own home environment: a reliability, responsiveness and feasibility study. Parkinsonism Relat Disord. 2005;11:19-24.
40. Steffen TM, Seney M. Test-retest reliability and minimal detectable change on balance and ambulation tests, the 36-Item Short-Form Health Survey, and the Unified Parkinson Disease Rating Scale in people with parkinsonism. Phys Ther. 2008;88:733-746.
41. Campbell CM, Rowse JL, Ciol MA, Shumway-Cook A. The effect of cognitive demand on Timed Up and Go performance in older adults with and without Parkinson disease. Neurol Rep. 2003;27:2-7.
42. Kumar A, Krol G. Binocular infrared oculography. Laryngoscope. 1992;102:367-378.
43. Zampieri C, Di Fabio RP. Improvement of gaze control following balance and eye movement training in patients with progressive supranuclear palsy: a quasi-randomized controlled trial. Arch Phys Med Rehabil. In press.
44. Cohen J. Statistical Power Analysis for the Behavioral Sciences. New York, NY: Academic Press; 1969.
45. Crowdy KA, Kaur-Mann D, Cooper HL, et al. Rehearsal by eye movement improves visuomotor performance in cerebellar patients. Exp Brain Res. 2002;146: 244-247.
46. Dickson D, Rademakers R, Hutton M. Progressive supranuclear palsy: pathology and genetics. Brain Pathol. 2007;17:74-82.
47. Rubinstein TC, Giladi N, Hausdorff JM. The power of cueing to circumvent dopamine deficits: a review of physical therapy treatment of gait disturbances in Parkinson's disease. Mov Disord. 2003;17:1148-1160.
48. Trend P, Kaye J, Gage H, et al. Short-term effectiveness of intensive multidisciplinary rehabilitation for people with Parkinson's disease and their carers. Clin Rehabil. 2002;16:717-725.
49. Blin O, Ferrandes A, Pailhous J, Serratrice G. Dopa-sensitive and dopa-resistant gait parameters in Parkinson's disease. J Neurol Sci. 1991;103:51-54.
50. Collins S, Ahlskog J, Parisi J, Maraganore D. Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria. J Neurol Neurosurg Psychiatry. 1995;58:167-173.
51. Hauw J, Daniel S, Dickson D. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology. 1994; 44:2015-2019.
52. Yamada T, Calne DB, Akiyama H, et al. Further observations on Tau-positive glia in the brains with progressive supranuclear palsy. Acta Neuropathol. 1993;85: 308-315.
53. Juncos J, Hirsch E, Malessa S, et al. Mesencephalic cholinergic nuclei in progressive supranuclear palsy. Neurology. 1991;41: 25-30.
54. Jellinger K. The pedunculopontine nucleus in Parkinson's disease, progressive supranuclear palsy and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1988; 51:540-543.
55. Mena-Segovia J, Bolam JP, Magill PJ. Pedunculopontine nucleus and basal ganglia: distant relatives of part of the same family? Trends Neurosci. 2004;27:585-588.
56. Warren NM, Piggott MA, Perry EK, Burn DJ. Cholinergic systems in progressive supranuclear palsy. Brain. 2005;128:239-249.
57. Miler NR, Newman NJ. The ocular motor system. In: Miller NR, Newman NJ, eds. Walsh and Hoyt's Clinical Neuro-Ophthalmology. Vol 1. Baltimore, MD: Williams & Wilkins; 1998:1043-1505.
58. Pahaphill PA, Lozano AM. The pedunculopontine nucleus and Parkinson's disease. Brain. 2000;123:1767-1783.
59. Shumway-Cook A, Brauer S, Woollacott M. Predicting the probability for falls in community-dwelling older adults using the Timed Up & Go Test. Phys Ther. 2000;80:896-903.
60. Kerrigan DC, Lee LW, Collins JJ, et al. Reduced hip extension during walking: healthy elderly and fallers versus young adults. Arch Phys Med Rehabil. 2001; 82:26-30.
61. Bower JH, Marangone DM, McDonnell SK, Rocca WA. Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990. Neurology. 1997;49:1284-1288.
62. Glass G, McGaw B, Smith M. Meta-Analysis in Social Research. London, United Kingdom: Sage Publications; 1981.